TB
Tempero Bio, Inc.
SEC filingBiotechnology · Oakland, CA
Amount raised$77Msold at filing
Total offering$77M
Investors in the raise23count reported to the SEC
FiledNov 4, 2025first sale Oct 30, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christian KleeExecutive Officer
Joshua GertsmanDirector
Paul JohnsonExecutive Officer, Director
Ricardo DolmetschExecutive Officer, Director
Julie ShahExecutive Officer
Joseph JimenezDirector
Francisco GimenezDirector
Executive officers, directors and promoters as listed on the Form D.